DIVIDEND GROWTH

Pharmaceutical stocks have been overlooked for years. But now, AI is changing the game. It can speed up drug development. This could cut the time from 15 years to just 6. That's big news for the industry. Two companies stand out. Becton Dickinson (BDX) and the BlackRock Health Sciences Fund (BME).

You might remember my last article about Microsoft Corporation (NASDAQ: MSFT) where I said, "Don't bother with the price now. " Back then, Microsoft's stock was valued at around 40 times its Blended P/E. As a financial analyst with 30 years until retirement, I'm using my time at a big-name firm to c